Home Part of States Newsroom
News
At the fringes of treatment options, some Montanans find hope through psychedelics

Share

At the fringes of treatment options, some Montanans find hope through psychedelics

Feb 25, 2024 | 12:19 pm ET
By Emily Tschetter
Share
At the fringes of treatment options, some Montanans find hope through psychedelics
Description
Psilocybin is a chemical derived from some types of psilocybe mushrooms. Psilocybin is often ingested for its hallucinogenic effects, but many people are beginning to use it in microdoses to manage symptoms of anxiety, depression and other mental health issues. (Photo by Brooklyn Grubbs for Byline Magazine.)

 

About this series

During February and March, the Daily Montanan is collaborating with students at the University of Montana to present the School of Journalism’s work on the topic of mental health in Montana. Each Sunday, the Daily Montanan will spotlight one of the stories that was featured in Byline magazine, which showcases the work of UM journalists and photojournalists. The entire series with complete photos can be found here.

Students in the University of Montana School of Journalism produce a magazine every other year as part of their capstone experience. 

Please note that several of the stories contain potentially triggering material. Don’t be reluctant to seek help if you or someone you know is in danger. Call or text the mental health crisis line at 988 or reach out to local resources to get the help you need.

A new ‘journey’

At the fringes of treatment options, some Montanans find hope through psychedelics
Kaley Burke works in many forms of holistic healing. She is a certified death doula, reiki instructor and a ketamine therapy administrator. (Photo by Brooklyn Grubbs of Byline Magazine)

Have a safe trip

At the fringes of treatment options, some Montanans find hope through psychedelics
Grace Porges, originally from Georgia, is a sophomore at the University of Montana. During the past few years, she has tried SSRIs, ketamine-assisted therapy and microdosing psilocybin to manage her depression. (Photo by Brooklyn Grubbs)

The cost of care

Phasing in psychedelics